Status:
COMPLETED
Effect of Different Exercise Modalities on Cardiovascular and Cognitive Response in Postmenopausal Women
Lead Sponsor:
University of Poitiers
Conditions:
Menopause
Blood Pressure
Eligibility:
FEMALE
45-65 years
Phase:
NA
Brief Summary
Menopause is a natural stage in female aging, increasing cardiometabolic risk and making cardio-neuro-vascular disease (CNVD) the leading cause of mortality in women over 60. Declining ovarian hormone...
Detailed Description
Menopause is a natural stage in the female aging process, resulting in increased cardiometabolic risk, making cardio-neuro-vascular disease (CNVD) the leading cause of female mortality worldwide after...
Eligibility Criteria
Inclusion
- Menopausal women (absence of menstruation for 12 consecutive months) for less than 10 years
- Women with or without vasomotor symptoms
- Women covered by the French Social Security system
Exclusion
- Surgical menopause (oophorectomy)
- Premature ovarian failure
- Chronic renal failure
- Respiratory pathology (unstable asthma, respiratory insufficiency or pulmonary hypertension)
- Cardiovascular disease (coronary, valvular, hypertrophic, hypertensive, infiltrative, constrictive or rhythmic)
- Medically treated hypertension
- Severe obesity (BMI \> 40 kg/m²)
- Hearing or vision problems that prevent reading or distinguishing colors
- Recent (\< 1 year) central neurological or psychiatric disorders
- Moderate to severe cognitive impairment (MoCA \< 18).
- Judicial protection or guardianship
Key Trial Info
Start Date :
March 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06533982
Start Date
March 10 2023
End Date
December 20 2023
Last Update
August 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Sport Science - MOVE Laboratory (UR20296)
Poitiers, France, 86000